Keros Therapeutics Inc (KROS)
17.03
+0.11
(+0.65%)
USD |
NASDAQ |
Dec 20, 16:00
16.73
-0.30
(-1.76%)
After-Hours: 04:36
Keros Therapeutics Market Cap: 689.84M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aptevo Therapeutics Inc | 2.181M |
| Corcept Therapeutics Inc | 5.389B |
| Regeneron Pharmaceuticals Inc | 77.13B |
| Scholar Rock Holding Corp | 4.194B |
| Trevi Therapeutics Inc | 311.31M |
Market Cap Related Metrics
| PS Ratio | 912.41 |
| PEG Ratio | -0.6223 |
| Price to Book Value | 1.295 |
| Price | 17.03 |
| Earnings Yield | -30.59% |
| PEGY Ratio | -0.6223 |